COMPANY
FDA-cleared device company Clinical Phase 2
Cothera Bioscience is a clinical stage biotech company. From company website Source · Oct 12, 2026
Keywords: clinical High-grade B-cell Lymphoma Burkitt Lymphoma B-Cell Lymphoma Lymphoma, Large B-Cell, Diffuse Lymphatic Diseases High-Grade Lymphoma C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma C-Myc Gene Rearrangement Sepantronium
Profile checked Oct 10, 2026
Timeline
- Trial start Phase 2: Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT05263583 | Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma | Phase 2 | Active, not recruiting | Dec 9, 2022 | Mar 1, 2025 (estimated) |
